Jeena Sikho Lifecare has announced a board meeting on May 20, 2025, to discuss the financial results for the quarter and half-year. FY25 revenue rose 45% YoY to ₹469 Cr, supported by expanded capacity to 1,600 beds and a strong pipeline of 1,218 beds. IPD volumes jumped 87% to 24,578. The products division grew 16% to ₹215 Cr, boosted by new launches and OTC channel growth. Margins compressed due to higher procurement and employee costs during rapid scaling.